LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
20 hedge funds and large institutions have $12.5M invested in LAVA Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
50% less call options, than puts
Call options by funds: $102K | Put options by funds: $203K
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
20
Holding in Top 10
–
Calls
$102K
Puts
$203K
Top Buyers
| 1 | +$809K | |
| 2 | +$340K | |
| 3 | +$181K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$40.3K |
| 5 |
Two Sigma Advisers
New York
|
+$36.7K |
Top Sellers
| 1 | -$2.97M | |
| 2 | -$1.33M | |
| 3 | -$86.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$47.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$18.1K |